- Advertising
- Asia
- Bangladesh
- Biological Inventions
- BRAND VALUATION
- China
- Comparative Advertisement
- Copyright
- Copyright Infringement
- Copyright Litigation
- Counterfeiting
- Covid
- Data Protection
- Design
- Digital Marketing Rights
- DRM
- Electronics
- Geographical Indication
- India
- Indian Patents Act
- Indonesia
- Intellectual Property
- Interim Injunction
- IP Commercialization
- IP Licensing
- IP Litigation
- IP Practice in India
- IPAB
- IPAB Decisions
- Japan
- Legal Issues
- Licensing
- Malaysia
- Myanmar
- NCLT
- NEPAL
- Net Neutrality
- News & Updates
- Office
- Patent Commercialisation
- Patent Cooperation Treaty
- patent infringement
- Patent Licensing
- Patent Litigation
- Patent Opposition
- Patent Prosecution
- Patent Rule Amendment
- Patent Term Extension
- Patents
- pharma
- Philippines
- Punitive Damages
- Section 3(D)
- section 64
- Singapore
- South-east Asia
- Technology
- Technology Transfer
- Thailand
- Trademark
- Trademark Litigation
- UAE
- Uncategorized
- USPTO
- Vietnam
- WIPO
Musical Work Used Commercially And Its Licensing Requirements
You cannot play music for your employees or the public in an office or shop or any commercial spaces, no matter what the medium is (phone system, radio, and disc, TV, or Bluetooth speakers). Business organizations or Entities that are interested in having singers sing or perform in their premises for any purpose need to … Continue reading Musical Work Used Commercially And Its Licensing Requirements
Read more »BlackBerry Limited To Sell Non-Core Legacy Patents To Catapult IP
Recently, Canadian company BlackBerry Limited (“BlackBerry”), originally known as Research-in-Motion, for the BlackBerry brand of interactive pagers, smartphones, and tablets, announced that it has entered into a patent sale agreement with Catapult IP Innovations Inc., a Delaware, US based company. Under this patent sale agreement, BlackBerry will sell substantially all of its non-core patent assets … Continue reading BlackBerry Limited To Sell Non-Core Legacy Patents To Catapult IP
Read more »A Brief Analysis Of Compulsory Licensing Pertinent To Copyright Law
Introduction As the title suggests, this particular blog deals with the compulsory licensing of copyright in our country. However, in order to understand compulsory licensing, the concept pertinent to “licenses” needs to be grasped first. Licenses are of two categories: one being voluntary license and the other being compulsory license. Section 30 of the Copyright … Continue reading A Brief Analysis Of Compulsory Licensing Pertinent To Copyright Law
Read more »Who Can Grant A Copyright License In Respect Of Creative Works: A Conundrum Unresolved
Introduction: The 2012 Amendment to the Copyright Act imposed onerous obligations on “providing or giving license” in respect of the above-mentioned works [in addition to the obligations imposed by the Copyright (Amendment) Act, 1994 (1994 Amendment)]. Section 33 of the Act, added by the 1994 Amendment, stated that only copyright societies are permitted to issue … Continue reading Who Can Grant A Copyright License In Respect Of Creative Works: A Conundrum Unresolved
Read more »Acacia Research Announces Patent Licensing Agreement on Wi-Fi 6 Technology with Samsung
Recently, Acacia Research Corporation (“Acadia”), announced that its subsidiary, Atlas Global Technologies LLC, has granted a license to Samsung Electronics Co., Ltd., and Samsung Electronics America, Inc. (“Samsung”) related to Atlas Global’s Wi-Fi 6 standard essential patents and resolved patent litigation between the two parties. Under this settlement, Samsung Electronics has executed a license agreement … Continue reading Acacia Research Announces Patent Licensing Agreement on Wi-Fi 6 Technology with Samsung
Read more »ERS Genomics Licenses CRISPR-Cas9 patent and technology to Cellular Engineering Technologies
Recently, Dublin, Ireland-based biotechnology company, ERS Genomics Limited (“ERS”), has signed a nonexclusive license agreement with Iowa-based Cellular Engineering Technologies (“CET”) to grant access to its CRISPR-Cas9 patent portfolio. The financial terms of the agreement were not disclosed. ERS was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property for use as a … Continue reading ERS Genomics Licenses CRISPR-Cas9 patent and technology to Cellular Engineering Technologies
Read more »Sun Pharma and Celegene Settle Patent Dispute over Lenalidomide (Revlimid®)
Settling an over three old patent infringement dispute, Indian pharmaceutical major, Sun Pharmaceuticals and its subsidiary, including US subsidiary (“Sun”), has reached a settlement with Celgene Corporation (“Celgene”), a subsidiary of pharmaceutical major Bristol Myers Squibb (BMS), to resolve and settle the patent litigation regarding submission of an Abbreviated New Drug Application (ANDA) for a … Continue reading Sun Pharma and Celegene Settle Patent Dispute over Lenalidomide (Revlimid®)
Read more »Twinstrand Biosciences Licenses Patented DNA Sequencing Technology To Foundation Medicine
Recently TwinStrand Biosciences entered into an worldwide non-exclusive agreement to sublicense its DNA sequencing technology to Foundation Medicine. TwinStrand Biosciences is a Bellevue, Washington based company working in the field of DNA sequencing technologies. Foundation Medicine is a US based company involved in the development and manufacture of profiling assays based on cutting-edge sequencing technologies. … Continue reading Twinstrand Biosciences Licenses Patented DNA Sequencing Technology To Foundation Medicine
Read more »Patent License Dispute Between Ericsson And Samsung
Recently, Swedish telecom company Ericsson has filed a lawsuit in the US against South Korean company Samsung for breach of contractual commitments and failure to negotiate the patent licensing and payment terms in good faith, essentially under FRAND (Fair, Reasonable and Non-discriminatory) terms. In the suit, Ericsson is also looking for a declaratory ruling that … Continue reading Patent License Dispute Between Ericsson And Samsung
Read more »Patent Royalty Agreement
INTRODUCTION The royalty agreement of patent means that a person having the patented products is ready to delegate his exclusive rights to some extent in the form of license to a person who shall be known as a licensee who would further use, manufacture, or whatsoever under the provided patent and would pay royalty amount … Continue reading Patent Royalty Agreement
Read more »